165 related articles for article (PubMed ID: 16957012)
1. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome.
Lee HY; Choi HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Kim MJ; Shin SK
Nephrol Dial Transplant; 2006 Oct; 21(10):2893-9. PubMed ID: 16957012
[TBL] [Abstract][Full Text] [Related]
2. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).
Lee HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Ahn C; Kim MJ; Shin SK
Perit Dial Int; 2005; 25(3):248-55. PubMed ID: 15981773
[TBL] [Abstract][Full Text] [Related]
3. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
4. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
[TBL] [Abstract][Full Text] [Related]
5. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre.
Fang W; Qian J; Lin A; Rowaie F; Ni Z; Yao Q; Bargman JM; Oreopoulos DG
Nephrol Dial Transplant; 2008 Dec; 23(12):4021-8. PubMed ID: 18790809
[TBL] [Abstract][Full Text] [Related]
6. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.
Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV
Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847
[TBL] [Abstract][Full Text] [Related]
7. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
8. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
[TBL] [Abstract][Full Text] [Related]
9. Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.
Rojas-Campos E; Alcántar-Medina M; Cortés-Sanabria L; Martínez-Ramírez HR; Camarena JL; Chávez S; Flores A; Nieves JJ; Monteón F; Gómez-Navarro B; Cueto-Manzano AM
Rev Invest Clin; 2007; 59(3):184-91. PubMed ID: 17910410
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre.
Chung SH; Heimbürger O; Lindholm B; Lee HB
Nephrol Dial Transplant; 2005 Jun; 20(6):1207-13. PubMed ID: 15784640
[TBL] [Abstract][Full Text] [Related]
11. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
[TBL] [Abstract][Full Text] [Related]
12. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal pressure in PD patients: relationship to intraperitoneal volume, body size and PD-related complications.
Dejardin A; Robert A; Goffin E
Nephrol Dial Transplant; 2007 May; 22(5):1437-44. PubMed ID: 17308323
[TBL] [Abstract][Full Text] [Related]
14. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients.
Han SH; Lee SC; Ahn SV; Lee JE; Kim DK; Lee TH; Moon SJ; Kim BS; Kang SW; Choi KH; Lee HY; Han DS
Nephrol Dial Transplant; 2007 Sep; 22(9):2653-8. PubMed ID: 17517797
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF).
Castrale C; Evans D; Verger C; Fabre E; Aguilera D; Ryckelynck JP; Lobbedez T
Nephrol Dial Transplant; 2010 Jan; 25(1):255-62. PubMed ID: 19666656
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible dialysis fluids for peritoneal dialysis.
Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
[TBL] [Abstract][Full Text] [Related]
17. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.
Haag-Weber M; Krämer R; Haake R; Islam MS; Prischl F; Haug U; Nabut JL; Deppisch R;
Nephrol Dial Transplant; 2010 Jul; 25(7):2288-96. PubMed ID: 20197284
[TBL] [Abstract][Full Text] [Related]
18. Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: prospective cross-over study with a three-compartment bag.
Cappelli G; Bandiani G; Cancarini GC; Feriani M; Dell'Aquila R; Saffioti S; Spisni C; Stingone A; Orazi E; Ballocchi S; Renaux JL
Adv Perit Dial; 1999; 15():238-42. PubMed ID: 10682110
[TBL] [Abstract][Full Text] [Related]
19. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]